Overview of the costs of the screening programme, utilities and costs of HBV and HCV disease and treatment in Euro (2016).</p
International audienceBackground: The economic impact of extrahepatic manifestations of hepatitis C ...
Background and study aims : Chronic hepatitis C virus (HCV) infection is a serious global health pro...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
Total costs of the primary care HCV treatment program, related to staffing and wholesale acquisition...
<p>Selection of studies on cost-effectiveness of HCV screening; September 2011 until July 2015.</p
Hepatitis C virus (HCV) infection is a systemic disease associated with both hepatic and extrahepati...
Incremental cost-effectiveness of screening migrant groups for the ten countries of origin with the ...
<p>Selection of studies on cost-effectiveness of HCV screening until November 2011.</p
Total Costs and revenue of primary care HCV treatment program, according to presence or absence of t...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
<p>The cost of treatment coverage with sofosbuvir or ledipasvir/sofosbuvir of different proportions ...
Background: Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a ...
Aim To evaluate the cost-consequences of the investment for anti-hepatitis C virus (HCV) treatment b...
BACKGROUND AND AIMS: A previous analysis of hepatitis C virus (HCV)-related healthcare costs in Swit...
Background and Aims: The epidemiology of hepatitis B in Europe is changing, with migration causing s...
International audienceBackground: The economic impact of extrahepatic manifestations of hepatitis C ...
Background and study aims : Chronic hepatitis C virus (HCV) infection is a serious global health pro...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
Total costs of the primary care HCV treatment program, related to staffing and wholesale acquisition...
<p>Selection of studies on cost-effectiveness of HCV screening; September 2011 until July 2015.</p
Hepatitis C virus (HCV) infection is a systemic disease associated with both hepatic and extrahepati...
Incremental cost-effectiveness of screening migrant groups for the ten countries of origin with the ...
<p>Selection of studies on cost-effectiveness of HCV screening until November 2011.</p
Total Costs and revenue of primary care HCV treatment program, according to presence or absence of t...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...
<p>The cost of treatment coverage with sofosbuvir or ledipasvir/sofosbuvir of different proportions ...
Background: Infection with the Hepatitis C Virus (HCV) is a widespread transmittable disease with a ...
Aim To evaluate the cost-consequences of the investment for anti-hepatitis C virus (HCV) treatment b...
BACKGROUND AND AIMS: A previous analysis of hepatitis C virus (HCV)-related healthcare costs in Swit...
Background and Aims: The epidemiology of hepatitis B in Europe is changing, with migration causing s...
International audienceBackground: The economic impact of extrahepatic manifestations of hepatitis C ...
Background and study aims : Chronic hepatitis C virus (HCV) infection is a serious global health pro...
Chronic hepatitis C (HCV) is a public health priority in the European Union/European Economic Area (...